5Drucker DJ.The role of gut hormones in glucose homeostasis[J].J Clin Invest,2007,117(1):24-32.
6Drucker DJ.Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes:preclinical biology and mechanisms of action[J].Diabetes Care,2007,30(6):1335-1343.
7Chung HS,Suh S,Kim MY,et al.Predictive factors of durability to sitagliptin:Slower reduction of glycated hemoglobin,older age and higher baseline glycated hemoglobin[J].J Diabetes Investig,2014,5(1):51-59.
8Mori H,Okada Y,Arao T,et al.Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus[J].J Diabetes Investig,2014,5(3):313-319.
9Lankas GK.Dipeptidyl peptidase ⅣV inhibition for the treatment of type 2 diabetes:potential importance of selectivity over dipeptidyl peptidases 8 and 9[J].Diabetes,2005,54(10):2988-2994.
10Mohan V,Yang W,Son HY,et al.Efficacy and safety ofsitagliptin in the treatment of patients with type 2 diabetes in China,India,and Korea[J].Diabetes Res Clin Pract,2009,83(1):106-116.
